Severe hypercalcemia and hypernatremia associated with calcipotriol for treatment of psoriasis

Journal of Bone and Mineral Metabolism

Volumn 22, Issue 2, 2004, Pages 159-162

  Kawahara, Chie ^a   Okada, Yosuke ^a   Tanikawa, Takahisa ^a   Fukusima, Ayumi ^a   Misawa, Haruo ^a   Tanaka, Yoshiya ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONVALESCENCE; DISEASE SEVERITY; FEMALE; HUMAN; HYPERCALCEMIA; HYPERNATREMIA; LABORATORY TEST; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSORIASIS; RARE DISEASE;

AGED; AGED, 80 AND OVER; CALCITRIOL; DERMATOLOGIC AGENTS; FEMALE; HUMANS; HYPERCALCEMIA; HYPERNATREMIA; OINTMENTS; PSORIASIS;

EID: 1642504748     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-003-0465-z     Document Type: Article

References (21)

1. Berth-Jones J (1998) The emergence of vitamin D as a first-line treatment for psoriasis. J Dermatol Treat 9 (Suppl 3):13-18
2. Berth-Jones J, Hutchinson PE (1992) Vitamin D analogues and psoriasis. Br J Dermatol 127:71-78
3. Binderup L, Bramm E (1988) Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol 37:889-895
4. Kragballe K, Fogh K, Soggard H (1991) Long-term efficacy and tolerability of topical calcipotriol in psoriasis. Acta Dermatol Venereol 71:475-478
5. Jansen TL, Jansen M, de Jong AJ (1997) Severe hypercalcemia syndrome with daily low-dose vitamin D supplementation. Br J Rheumatol 36:712-713
6. Pettifor JM, Bikle DD, Cavaleros M, Zachen D, Kamdar MC, Ross FP (1995) Serum levels of free 1,25-dihydroxyvitamin D in vitamin D toxicity. Ann Intern Med 122:511-513
7. 3. J Clin Endocrinol Metab 56:824-830
8. 3 receptors inhuman skin biopsies. J Clin Endocrinol Metab 51:1463-1465
9. 3. Arch Dermatol 123:1677-1683
10. 3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 7:709-714
11. 3 MC903 and their analogues herald a new pharmacologic era for the treatment of psoriasis? Arch Dermatol 125:1695-1697
12. Hoeck HC, Laurberg G, Laurberg P (1994) Hypercalcaemic crisis after excessive topical use of a vitamin D derivative. J Intern Med 235:281-282
13. 3. Biochem Pharmacol 41:1601-1606
14. Bower M, Colston KW, Stein RC, Hedley A, Gazet JC, Ford HT, Combes RC (1991) Topical calcipotriol treatment of advanced breast cancer. Lancet 337:701-702
15. Bourke JF, Iqbal SJ, Hutchinson PE (1996) Vitamin D analogues in psoriasis: effects on systemic calcium homeostasis. Br J Dermatol 135:345-347
16. Bourke JF, Mumford R, Whittaker P, Iqbal SJ, Le Van LW, Trevellyan A, Hutchinson PE (1997) The effects of topical calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis. J Am Acad Dermatol 37:929-934
17. Hardman KA, Heath DA, Nelson HM (1993) Hypercalcaemia associated with calcipotriol (Dovonex) treatment. Br Med J 306:896
18. Bourke JF, Mumford R, Whittaker P, Iqbal SJ, Le Van LW, Trevellyan A, Hutchinson PE (1997) The effects of topical calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis. J Am Acad Dermatol 37:929-934
19. Azuma J, Iwasa M, Aoki T, Hamaguchi T, Ishizuki K (1995) Study on safety and pharmacokinetics of MC 903 ointment in normal volunteers: phase I study (in Japanese). Rinsho Iyaku 11:2341-2366
20. 3H-calcipotriene following multiple dose treatment with non-radiolabeled calcipotriene 0.005% ointment. J Invest Dermatol Symp Proc April:112
21. Yoshikawa K, Nomura M, Higashiyama M, Muya M, Nakamura T, Ohata C, Hnakawa Y, Tezuka T, Yoshida M, Matsukura M, Sugihara K, Tamura T, Yamauchi K, Sugiyama Y (1995) Clinical pharmacological study on MC903 ointment: pharmacokinetic investigation in patients with psoriasis vulgaris (in Japanese). Rinsho Iyaku 11:2379-2389